AAV residual host-cell DNA testing | To ensure the quality and the purity of clinical grade rAAV batches, the Food and Drug Administration and the European Pharmacopoeia published a series of compulsory quality control assays. The presence of residual DNA in the final product is an important problem. These fragments may be derived from the host cell genome, the plasmid DNA, or helper virus sequences used for production. |
Forums
Explore the Forum Portal on Webyourself.eu, a vibrant community of web enthusiasts and professionals. Share insights, ask questions, and engage in enriching discussions that elevate your digital journey. Immerse yourself in the collective wisdom of the web, right here!